Bristol-Myers Squibb (NYSE:BMY) Sees Rising Interest in Sotyktu Despite 3% Share Price Dip
Bristol-Myers Squibb (NYSE:BMY) recently announced positive topline results from its Phase 3 trials for Sotyktu, generating ...
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
Shares of Bristol Myers Squibb Co. BMY advanced 1.90% to $60.02 Friday, on what proved to be an all-around dismal trading ...
Why Pfizer Is My Largest Healthcare Position
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...
Bristol-Myers Squibb's Rally Is Well Deserved, Albeit Warranting A Downgrade To Hold
BMY has enjoyed robust capital appreciation over the past few months, significantly aided by the ongoing market rotation to ...
Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better
We recently published a list of Jim Cramer Discusses These 11 Stocks & Reveals Why Tech Stocks Are Down. In this article, we ...
Medical Dialogues2h
Bristol Myers Squibb gets Positive EMA Committee opinion for subcutaneous formulation of Opdivo across Multiple Solid Tumor Indications
Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors
This was the stock's second consecutive day of losses.
Crain's New York Business18h
Bristol-Myers CEO awarded $19M after a difficult year
Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the ...
Bristol Myers Squibb put volume heavy and directionally bearish
Bearish flow noted in Bristol Myers ( BMY) Squibb with 13,765 puts trading, or 2x expected. Most active are Apr-25 60 puts and 4/4 weekly 60 puts, with total volume in those strikes near 8,600 ...
3 Deeply Discounted Dividend Stocks to Buy Today
Three stocks that are trading at attractive valuations right now that you may not want to overlook are Bristol Myers Squibb ( ...
Analysts Set Bristol-Myers Squibb (NYSE:BMY) Target Price at $57.86
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) has been assigned a consensus rating of “Hold” from the nineteen brokerages that are covering the company, Marketbeat.com reports. Two research ...
Bristol Myers announces CHMP recommendation for Opdivo formulation approval
Bristol Myers (BMY) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval ...